RSS-Feed abonnieren
DOI: 10.1055/s-2004-831374
© Georg Thieme Verlag Stuttgart · New York
Aszites - Diagnostik und Therapie
Diagnosis and treatment of ascitesPublikationsverlauf
eingereicht: 5.5.2004
akzeptiert: 13.8.2004
Publikationsdatum:
15. September 2004 (online)

Glossar
ADH = Antidiuretisches Hormon
HRS = hepatorenales Syndrom
RAAS = Renin-Angiotensin-Aldosteronsystem
SNS = sympathisches Nervensystem
SBP = spontane bakterielle Peritonitis
TIPS = transjugulärer intrahepatischer portosystemischer Shunt
Literatur
- 1
Angeli P, Volpin R, Gerunda G. et al .
Reversal of type 1 hepatorenal syndrome with the administration of midodrine
and octreotide.
Hepatology.
1999;
29
1690-1697
MissingFormLabel
- 2
Arroyo V, Gines P, Gerbes A L. et al .
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome
in cirrhosis.
Hepatology.
1996;
23
164-176
MissingFormLabel
- 3
Brensing K A, Textor J, Perz J. et al .
Long term outcome after transjugular intrahepatic portosystemic stent-shunt
in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.
Gut.
2000;
47
288-295
MissingFormLabel
- 4
Ginès A, Escorsell A, Ginès P. et al .
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in
cirrhosis with ascites.
Gastroenterology.
1993;
105
229-236
MissingFormLabel
- 5
Gines P, Tito L, Arroyo V. et al .
Randomized comparative study of therapeutic paracentesis with and without intravenous
albumin in cirrhosis.
Gastroenterology.
1988;
94
1493-1502
MissingFormLabel
- 6
Gonwa T A, Klintmalm G B, Levy M. et al .
Impact of pretransplant renal function on survival after liver transplantation.
Transplantation.
1995;
15 (59)
361-365
MissingFormLabel
- 7
Gülberg V, Bilzer M, Gerbes A L.
Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin
and dopamine.
Hepatology.
1999;
30
870-875
MissingFormLabel
- 8
Gülberg V, Gerbes A L.
Diagnostik und Therapie des Aszites bei Leberzirrhose.
Internist (Berl.).
1998;
39
254-262
MissingFormLabel
- 9
Gülberg V, Liss I, Bilzer M. et al .
Improved quality of life in patients with refractory or recidivant ascites after
insertion of transjugular intrahepatic portosystemic shunts.
Digestion.
2002;
66
127-130
MissingFormLabel
- 10
Moreau R, Durand F, Poynard T. et al .
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective
multicenter study.
Gastroenterology.
2002;
122
923-930
MissingFormLabel
- 11
Restuccia T, Ortega R, Guevara M. et al .
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation
outcome. A case-control study.
J Hepatol.
2004;
40
140-146
MissingFormLabel
- 12
Rössle M, Ochs A, Gülberg V. et al .
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting
in patients with ascites.
N Engl J Med.
2000;
342
1701-1707
MissingFormLabel
- 13
Schrier R W, Arroyo V, Bernardi M. et al .
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of
renal sodium and water retention in cirrhosis.
Hepatology.
1988;
8
1151-1157
MissingFormLabel
- 14
Sort P, Navasa M, Arroyo V. et al .
Effect of intravenous albumin on renal impairment and mortality in patients
with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med.
1999;
341
403-409
MissingFormLabel
Prof. Dr. med. Alexander L. Gerbes
Ludwig-Maximilians-Universität München, Medizinische Klinik II
Marchioninistraße 15
81366 München
Telefon: (0 89) 70 95-22 92
Fax: (0 89) 70 95-23 92
eMail: gerbes@med2.med.uni-muenchen.de